Form 4 for CBLL Ceribell, Inc.
Accepted 2025-12-29 00:00:00 ET · period of report 2025-11-20 · accession 0001193125-25-334657 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2025-12-29 | 2025-12-22 | CBLL | Blumberg Scott | CFO | M - OptEx | $4.23 | +36.0K | 138.6K | +35% | +$152.1K |
| DT | 2025-12-29 | 2025-11-20 | CBLL | Blumberg Scott | CFO | F - Tax | $13.64 | -687 | 118.8K | -0.6% | -$9,371 |
| DMT | 2025-12-29 | 2025-12-22 | CBLL | Blumberg Scott | CFO | S - Sale+OE | $21.00 | -36.0K | 118.8K | -23% | -$756.0K |
| DMT | 2025-12-29 | 2025-12-22 | CBLL | Blumberg Scott | CFO | M - OptEx | $0.00 | -36.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | M | A | 4,752 | $3.65 | 123,594 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-20 | F | D | 687 | $13.64 | 118,842 | D | — | — | (F1) Includes 155 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2025. |
| 3 | Common | Common Stock | 2025-12-22 | M | A | 11,529 | $3.65 | 130,371 | D | — | — | |
| 4 | Common | Common Stock | 2025-12-22 | S | D | 4,752 | $21.00 | 118,842 | D | — | — | |
| 5 | Common | Common Stock | 2025-12-22 | S | D | 19,719 | $21.00 | 118,842 | D | — | — | |
| 6 | Common | Common Stock | 2025-12-22 | M | A | 19,719 | $4.70 | 138,561 | D | — | — | |
| 7 | Common | Common Stock | 2025-12-22 | S | D | 11,529 | $21.00 | 118,842 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2025-12-22 | M | D | 4,752 | $0.00 | 0 | D | $3.65 · — to 2031-06-10 | 4,752 Common Stock | (F3) The stock option is fully vested and currently exercisable. |
| 9 | Derivative | Stock Option (Right to Buy) | 2025-12-22 | M | D | 19,719 | $0.00 | 6,869 | D | $4.70 · — to 2033-02-16 | 19,719 Common Stock | (F4) The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date. |
| 10 | Derivative | Stock Option (Right to Buy) | 2025-12-22 | M | D | 11,529 | $0.00 | 0 | D | $3.65 · — to 2031-12-02 | 11,529 Common Stock | (F3) The stock option is fully vested and currently exercisable. |